awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36277977-1AD51259-37ED-4DDA-9B41-ABE566FC429D
Q36277977-1AD51259-37ED-4DDA-9B41-ABE566FC429D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36277977-1AD51259-37ED-4DDA-9B41-ABE566FC429D
SGLT2 inhibitors - an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin.
P2860
Q36277977-1AD51259-37ED-4DDA-9B41-ABE566FC429D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36277977-1AD51259-37ED-4DDA-9B41-ABE566FC429D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
082ce9bfc6f959359e18822c91ae656035c78ce2
P2860
Canagliflozin: a review of its use in patients with type 2 diabetes mellitus.